Effect of a Symbiotic Drink on the Microbiota
KOMFIBRA
Nutritional Intervention Study to Evaluate the Effect of a Symbiotic Drink on the Microbiota and Different Nutritional Markers in Healthy Volunteers
1 other identifier
interventional
60
1 country
1
Brief Summary
This study is expected to involve 60 volunteers who will be recruited by IMDEA-Alimentación and randomly assigned between a study group (which will consume the fermented drink) and a control group, which will consume a drink with similar characteristics, but without the presence of bioactive components.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy-volunteers
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2024
CompletedFirst Submitted
Initial submission to the registry
September 30, 2024
CompletedFirst Posted
Study publicly available on registry
October 4, 2024
CompletedMay 9, 2025
May 1, 2025
2 months
September 30, 2024
May 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relative abundance of the gut microbial species
Analyze the variations in the relative abundance of the microbial species present, including taxonomic identification, diversity analysis, and phylogenetic composition.
6 weeks
Study Arms (2)
Study Group
EXPERIMENTALParticipants will consume a 250cl bottle of soluble fibre-enriched kombucha mid-morning or mid-afternoon, avoiding consumption after eating. The drink will be included in a healthy eating plan. They will be advised to continue their usual physical activity during the 6 weeks of the study.
Control Group
PLACEBO COMPARATORParticipants will consume one 250cl bottle of a similar unfermented and unfortified beverage mid-morning or mid-afternoon, avoiding consumption after eating. The beverage will be included in a healthy eating plan. Participants will be advised to continue their usual physical activity for the 6 weeks of the study.
Interventions
During Visit 1 (week 0), a fasting blood test must be performed at the IMDEA Alimentación facilities to obtain different markers: blood lipids, blood glucose, etc. Approximately 20 mL will be extracted (for comparison, keep in mind that a donation requires 450 mL). The blood sample will be extracted by qualified nursing staff from the UNILABS Laboratory. The blood tests based on the security and privacy requirements for handling samples will be carried out by the same laboratory. You will also be asked to provide the stool sample that you must have collected at home prior to attending that visit with the material provided at the screening visit (V0) and at the intermediate visit (V2).
Eligibility Criteria
You may qualify if:
- Men and women ≥ 18 years of age.
- Caucasian ethnicity
- Adequate level of culture and understanding of the clinical study.
- Agree to voluntarily participate in the study and give written informed consent.
You may not qualify if:
- Subjects with dementia, mental illness or decreased cognitive function that prevents the study from being carried out.
- Subjects with serious diseases (liver, kidney, immunosuppressed, etc.).
- BMI ≥ 30 kg/m2, pregnant or breastfeeding women.
- Presence of immunological pathologies, gallstones, gastric ulcer or coagulation problems.
- Presence of any other specific pathology that contraindicates the intake of dietary supplements, specifically inulin and probiotics (diverticulitis, etc.).
- Subjects who are undergoing antibiotic treatment or consuming probiotic supplements.
- Subjects who are undergoing pharmacological treatment for weight loss.
- Subjects who refuse to follow the guidelines for healthy eating or the consumption of the study drink in the indicated guidelines.
- Non-Caucasian ethnicity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IMDEA Foodlead
Study Sites (1)
Imdea Food
Madrid, Madrid, 28049, Spain
Related Publications (1)
Arce-Lopez B, Bazan GX, Molina S, Crespo MC, Garcia-Beccaria M, Cruz-Gil S, Fernandez-Diaz CM, Ramirez de Molina A, Ramos-Ruiz R, Espinosa-Salinas MI. Effect of fiber-modified kombucha tea on gut microbiota in healthy population: A randomized controlled trial (RCT). Curr Res Food Sci. 2025 Jun 26;11:101130. doi: 10.1016/j.crfs.2025.101130. eCollection 2025.
PMID: 40689297DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The study will be masked by using identical packaging for both the study group and the control group (placebo), which participants will consume at home or at their mealtimes during the 6 weeks of the intervention. The researchers themselves will administer the product (with identical external appearance for both groups) individually to each participant.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 30, 2024
First Posted
October 4, 2024
Study Start
January 22, 2024
Primary Completion
March 14, 2024
Study Completion
June 28, 2024
Last Updated
May 9, 2025
Record last verified: 2025-05